The mucosal immune response to laryngopharyngeal reflux

American Journal of Respiratory and Critical Care Medicine

Volumn 177, Issue 11, 2008, Pages 1187-1193

  Rees, Louisa E N ^a   Pazmany, Laszlo ^b   Gutowska Owsiak, Danuta ^b   Inman, Charlotte F ^a   Phillips, Anne ^a   Stokes, Christopher R ^a   Johnston, Nikki ^c   Koufman, Jamie A ^d   Postma, Gregory ^e   Bailey, Michael ^a   Birchall, Martin A ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d Voice Institute of New York   (United States)

^e MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

CD1d; Epithelial cells; Laryngopharyngeal reflux; Natural killer T cells

Indexed keywords

BETA 2 MICROGLOBULIN; CD161 ANTIGEN; CD1D ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD68 ANTIGEN; CD79 ANTIGEN; CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; LEUKOCYTE ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; LARYNGEAL BIOPSY; LARYNGOPHARYNGEAL REFLUX; LARYNX MUCOSA; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MUCOSAL IMMUNITY; NATURAL KILLER T CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN LOCALIZATION; ANTIGEN PRESENTING CELL; CASE CONTROL STUDY; EPITHELIUM CELL; GASTROESOPHAGEAL REFLUX; HYPOPHARYNX; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY;

ADULT; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; CASE-CONTROL STUDIES; EPITHELIAL CELLS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; HYPOPHARYNX; IMMUNITY, MUCOSAL; LARYNGEAL MUCOSA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 44449125150     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200706-895OC     Document Type: Article

References (37)

1. Gillett S, Rees L, Cogan T, Birchall M, Bailey M. Characterisation of the bacterial flora of the larynx [abstract]. Clin Otolaryngol 2006;31:583.
2. Gorti GK, Birchall MA, Haverson K, Macchiarini P, Bailey M. A preclinical model for laryngeal transplantation: anatomy and mucosal immunology of the porcine larynx. Transplantation 1999;68:1638-1642.
3. Jecker P, McWilliam A, Marsh A, Holt PG, Mann WJ, Pabst R, Westermann J. Acute laryngotracheitis in the rat induced by Sendai virus: the influx of six different types of immunocompetent cells into the laryngeal mucosa differs strongly between the subglottic and the glottic compartment. Laryngoscope 2001;111:1645-1651.
4. Jecker P, Mann WJ, McWilliam AS, Holt PG. Dendritic cell influx differs between the subglottic and glottic mucosae during acute laryngotracheitis induced by a broad spectrum of stimuli. Ann Otol Rhinol Laryngol 2002;111:567-572.
5. Wang EC, Damrose EJ, Mendelsohn AH, Nelson SD, Shintaku IP, Ye M, Berke GS, Blackwell KE. Distribution of class I and II human leukocyte antigens in the larynx. Otolaryngol Head Neck Surg 2006;134:280-287.
6. Barker EV, Haverson K, Stokes CR, Birchall M, Bailey M. The larynx as an immunological organ. Clin Exp Immunol 2006;143:6-14.
7. Kracke A, Hiller AS, Tschernig T, Kasper M, Kleemann WJ, Troger HD, Pabst R. Larynx-associated lymphoid tissue (LALT) in young children. Anat Rec 1997;248:413-420.
8. Rees LE, Ayoub O, Birchall MA, Bailey M. Differential major histocompatibility complex class II locus expression on human laryngeal epithelium. Clin Exp Immunol 2003;134:497-502.
9. Rees LEN, Jones PH, Ayoub O, Gunasekaran S, Rajkumar K, Stokes CR, Haverson K, Bailey M, Birchall MA. Smoking influences the immunological architecture of the human larynx. Clin Immunol 2006;118:342-347.
10. Hobbs CGL, Rees LEN, Heyderman RS, Birchall MA, Bailey M. Quantitative differences in major histocompatibility complex class I expression in human tonsillar and laryngeal epithelium. Clin Exp Immunol 2006;145:365-372.
11. Gullberg E, Soderholm JD. Peyer's patches and M cells as potential sites of the inflammatory onset in Crohn's disease. Ann N Y Acad Sci 2006;1072:218-232.
12. Fontana GA, Pantaleo T, Lavorini F, Mutolo D, Polli G, Pistolesi M. Coughing in laryngectomized patients. Am J Respir Crit Care Med 1999;160:1578-1584.
13. Koufman JA, Amin MR, Panetti M. Prevalence of reflux in 113 consecutive patients with laryngeal and voice disorders. Otolaryngol Head Neck Surg 2000;123:385-388. [Published erratum appears in Otolaryngol Head Neck Surg 2001;124:104.]
14. Vaezi MF, Qadeer MA, Lopez R, Colabianchi N. Laryngeal cancer and gastroesophageal reflux disease: a case-control study. Am J Med 2006;119:768-776.
15. Johnston N, Dettmar PW, Postma GN, Lively MO, Belafsky PC, Birchall M, Koufman JA. Effect of pepsin on laryngeal stress protein (sep70, sep53, and hsp70) response: role in laryngopharyngeal reflux disease. Ann Otol Rhinol Laryngol 2006;115:47-58.
16. Bulmer D. Damage and protection of the laryngeal mucosa in reflux disease [Ph.D. dissertation]. Newcastle-upon-Tyne, UK: University of Newcastle-upon-Tyne; 2003.
17. Birchall M, Hobbs C, Phillips A, Bailey M, Rees LEN, Johnston N, Koufman J. MHC molecule expression in laryngeal epithelium of patients with laryngopharyngeal reflux compared to normal subjects. Clin Otolaryngol 2005;30:584.
18. Belafsky PC, Postma GN, Daniel E, Koufman JA. Transnasal esophagoscopy. Otolaryngol Head Neck Surg 2001;125:588-589.
19. Haverson K, Singha S, Stokes CR, Bailey M. Professional and non-professional antigen-presenting cells in the porcine small intestine. Immunology 2000;101:492-500.
20. Rees LEN, Sipaul F, Gunasekaran S, Birchall MA, Bailey M. The isolation and characterisation of primary human laryngeal epithelial cells. Mol Immunol 2006;43:725-730.
21. Inman C, Rees LEN, Barker EV, Haverson K, Stokes CR, Bailey M. Validation of computer-assisted, pixel-based analysis of multiple-colour immunofluorescence histology. J Immunol Methods 2005;302:156-167.
22. Somnay-Wadgaonkar K, Nusrat A, Kim HS, Canchis WP, Balk SP, Colgan SP, Blumberg RS. Immunolocalization of CD1d in human intestinal epithelial cells and identification of a beta2-microglobulin-associated form. Int Immunol 1999;11:383-392.
23. Porcelli SA, Modlin RL. CD1 and the expanding universe of T cell antigens. J Immunol 1995;155:3709-3710.
24. Bendelac A, Rivera MN, Park SH, Roark JH. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu Rev Immunol 1997;15:535-562.
25. Van Kaer L. NKT cells: T lymphocytes with innate effector functions. Curr Opin Immunol 2007;19:354-364.
26. Braud VM, Allan DS, McMichael AJ. Functions of nonclassical MHC and non-MHC-encoded class I molecules. Curr Opin Immunol 1999;11:100-108.
27. + T cells. Nature 1994;372:691-694.
28. Bleicher PA, Balk SP, Hagen SJ, Blumberg RS, Flotte TJ, Terhorst C. Expression of murine CD1 on gastrointestinal epithelium. Science 1990;250:679-682.
29. Bonish B, Jullien D, Dutronc Y, Huang BB, Modlin R, Spada FM, Porcelli SA, Nickoloff BJ. Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-gamma production by NK-T cells. J Immunol 2000;165:4076-4085.
30. Fishelevich R, Malanina A, Luzina I, Atamas S, Smyth MJ, Porcelli SA, Gaspari AA. Ceramide-dependent regulation of human epidermal keratinocyte CD1d expression during terminal differentiation. J Immunol 2006;176:2590-2599.
31. Gielen V, Schmitt D, Thivolet J. HLA class I antigen (heavy and light chain) expression by Langerhans cells and keratinocytes of the normal human epidermis: ultrastructural quantitation using immunogold labelling procedure. Arch Dermatol Res 1988;280:131-136.
32. Balk SP, Burke S, Polischuk JE, Frantz ME, Yang L, Porcelli S, Colgan SP, Blumberg RS. Beta 2-microglobulin-independent MHC class Ib molecule expressed by human intestinal epithelium. Science 1994;265:259-262.
33. Brigl M, van den Elzen P, Chen X, Meyers JH, Wu D, Wong CH, Reddington F, Illarianov PA, Besra GS, Brenner MB, et al. Conserved and heterogeneous lipid antigen specificities of CD1d-restricted NKT cell receptors. J Immunol 2006;176:3625-3634.
34. + T cells with regulatory function after interaction with intestinal epithelial cells. Gastroenterology 2002;123:1516-1526.
35. Stetson DB, Mohrs M, Reinhardt RL, Baron JL, Wang ZE, Gapin L, Kronenberg M, Locksley RM. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J Exp Med 2003;198:1069-1076.
36. Terabe M, Swann J, Ambrosino E, Sinha P, Takaku S, Hayakawa Y, Godfrey DI, Ostrand-Rosenberg S, Smyth MJ, Berzofsky JA. A nonclassical non-Valpha14Jalpha18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance. J Exp Med 2005;202:1627-1633.
37. Godfrey DI, McConville MJ, Pellicci DG. Chewing the fat on natural killer T cell development. J Exp Med 2006;203:2229-2232.